Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
| Revenue (Most Recent Fiscal Year) | $6.78B |
| Net Income (Most Recent Fiscal Year) | $711.50M |
| PE Ratio (Current Year Earnings Estimate) | 12.54 |
| PE Ratio (Trailing 12 Months) | 11.76 |
| PEG Ratio (Long Term Growth Estimate) | 3.88 |
| Price to Sales Ratio (Trailing 12 Months) | 1.17 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.38 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.02 |
| Pre-Tax Margin (Trailing 12 Months) | 0.94% |
| Net Margin (Trailing 12 Months) | -1.25% |
| Return on Equity (Trailing 12 Months) | 10.91% |
| Return on Assets (Trailing 12 Months) | 5.34% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.49 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.96 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.65 |
| Inventory Turnover (Trailing 12 Months) | 5.75 |
| Book Value per Share (Most Recent Fiscal Quarter) | $8.75 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.22 |
| Earnings per Share (Most Recent Fiscal Year) | $0.99 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.13 |
| Exchange | NYSE |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Common Shares Outstanding | 681.82M |
| Free Float | 673.63M |
| Market Capitalization | $7.70B |
| Average Volume (Last 20 Days) | 7.63M |
| Beta (Past 60 Months) | 0.93 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.08% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |